Table 2.
Protein ID | Protein names | Gene name | # of peptides | Mean |
P value |
|||
---|---|---|---|---|---|---|---|---|
N | D | DT | D-N | DT-D | ||||
Proteins increased in diabetic and decreased by calpain inhibitor | ||||||||
O884852; O88485 | Cytoplasmic dynein 1 | Dync1 | 10 | 0.27 | 0.58 | 0.18 | 0.03 | 0.007 |
Q9CR09 | Ubiquitin-fold modifier-conjugating enzyme 1 | Ufc1 | 2 | −3.92 | −3.08 | −1.08 | 0.04 | 0.02 |
Q91WL83; Q91WL8-4; Q91WL8; Q91WL8-2 | WW domain-containing oxidoreductase | Wwox | 4 | −3.55 | −1.75 | −2.94 | 0.002 | 0.01 |
P61226; Q80ZJ12; Q8BU31 | Ras-related protein Rap-2b; Ras-related protein Rap-2a; Ras-related protein Rap-2c | Rap2b; Rap2a;Rap2c | 6 | 1.14 | 1.55 | −0.66 | 0.02 | 0.04 |
O35654 | DNA polymerase delta subunit 2 | Pold2 | 3 | −2.36 | −1.98 | −3.25 | 0.02 | 0.02 |
Q8BYM5 | Neuroligin-3 | Nlgn3 | 5 | −1.18 | −0.43 | −1.10 | 0.02 | 0.02 |
Q91YP2 | Neurolysin, mitochondrial | Nln | 4 | −3.39 | −1.58 | −3.26 | 0.04 | 0.04 |
Proteins decreased in diabetic and increased by calpain inhibitor | ||||||||
E9Q735 | Ubiquitination factor E4A | Ube4a | 8 | 0.59 | 0.12 | 0.79 | 0.004 | 0.02 |
P15208 | Insulin receptor; insulin receptor subunit alpha; insulin receptor subunit beta | Insr | 3 | −3.32 | −4.02 | −2.78 | 0.03 | 0.01 |
P01872; P01872-2 | Ig mu chain C region | Ighm | 2 | −3.56 | −4.87 | −2.40 | 0.03 | 0.01 |
Q925N0 | Sideroflexin-5 | Sfxn5 | 11 | 2.25 | 1.74 | 2.22 | 0.05 | 0.01 |
P62488 | DNA-directed RNA polymerase II subunit RPB7 | Polr2g | 2 | −0.20 | −0.85 | −0.08 | 0.03 | 0.01 |
Q8CCJ42; Q8CCJ4 | APC membrane recruitment protein 2 | Amer2 | 2 | −0.32 | −4.03 | −0.32 | 0.001 | 0.01 |
Q9QZH6 | Evolutionarily conserved signaling intermediate in Toll pathway, mitochondrial | Ecsit | 2 | −3.64 | −4.35 | −3.13 | 0.02 | 0.02 |
P84099 | 60S ribosomal protein L19 | Rpl19 | 3 | 1.30 | −0.20 | 1.34 | 0.03 | 0.04 |
D, diabetic; DT, diabetic treated with calpain inhibitor; N, nondiabetic.